Federated Hermes, Inc. Ironwood Pharmaceuticals Inc Transaction History

Federated Hermes, Inc.

$50.2 Billion
Q2 2025

A detailed history of Federated Hermes, Inc. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 2,177,038 shares of IRWD stock, worth $3.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,177,038

Previous 1,305,362 66.78%

Holding current value

$3.44 Million

Previous $1.92 Million 18.3%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$0.57 - $1.44 $496,855 - $1.26 Million	871,676 Added 66.78%	2,177,038 $1.57 Million
Q1 2025 May 08, 2025	BUY	$1.41 - $4.58 $1.32 Million - $4.28 Million	934,886 Added 252.35%	1,305,362 $1.92 Million
Q4 2024 Feb 13, 2025	BUY	$3.34 - $5.04 $1.24 Million - $1.87 Million	370,476 New	370,476 $1.64 Million
Q2 2023 Aug 14, 2023	BUY	$10.1 - $11.6 $3,625 - $4,164	359 Added 50.92%	1,064 $11,000
Q1 2023 May 08, 2023	BUY	$10.37 - $12.56 $124 - $150	12 Added 1.73%	705 $7,000
Q4 2022 Feb 13, 2023	SELL	$9.9 - $12.43 $12,612 - $15,835	-1,274 Reduced 64.77%	693 $8,000
Q3 2022 Nov 14, 2022	SELL	$10.14 - $12.38 $12,157 - $14,843	-1,199 Reduced 37.87%	1,967 $20,000
Q2 2022 Aug 15, 2022	SELL	$11.05 - $12.72 $1.4 Million - $1.62 Million	-127,084 Reduced 97.57%	3,166 $37,000
Q1 2022 May 13, 2022	SELL	$10.61 - $12.88 $3.93 Million - $4.77 Million	-370,569 Reduced 73.99%	130,250 $1.64 Million
Q4 2021 Feb 14, 2022	BUY	$10.86 - $13.95 $6,722 - $8,635	619 Added 0.12%	500,819 $5.84 Million
Q3 2021 Nov 15, 2021	BUY	$11.92 - $13.92 $231,546 - $270,396	19,425 Added 4.04%	500,200 $6.53 Million
Q2 2021 Aug 16, 2021	SELL	$10.16 - $13.11 $67,188 - $86,696	-6,613 Reduced 1.36%	480,775 $6.19 Million
Q1 2021 May 13, 2021	SELL	$9.04 - $11.86 $138,845 - $182,157	-15,359 Reduced 3.06%	487,388 $5.45 Million
Q4 2020 Feb 12, 2021	BUY	$9.05 - $12.2 $12,724 - $17,153	1,406 Added 0.28%	502,747 $5.73 Million
Q3 2020 Nov 12, 2020	SELL	$8.99 - $10.74 $785,510 - $938,418	-87,376 Reduced 14.84%	501,341 $4.51 Million
Q2 2020 Aug 13, 2020	BUY	$9.14 - $11.97 $59,839 - $78,367	6,547 Added 1.12%	588,717 $6.08 Million
Q1 2020 May 13, 2020	BUY	$8.58 - $14.01 $656,241 - $1.07 Million	76,485 Added 15.13%	582,170 $5.87 Million
Q4 2019 Feb 14, 2020	BUY	$8.22 - $14.0 $3.24 Million - $5.52 Million	394,375 Added 354.3%	505,685 $6.73 Million
Q3 2018 Nov 13, 2018	BUY	$14.31 - $17.65 $1.59 Million - $1.96 Million	111,310 New	111,310 $2.06 Million

Others Institutions Holding IRWD

# of Institutions

177

Shares Held

160M

Call Options Held

11.2M

Put Options Held

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $242M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Ironwood Pharmaceuticals Inc Transaction History